抗病毒治疗是慢性乙型肝炎的根本治疗方法,其中聚乙二醇干扰素(PEG-IFN)α是一线治疗药物之一.目前,PEG-IFNα个体化治疗方面已经达成多项共识,在临床实践中发挥了重要作用.随着其临床应用不断深入,逐步涌现出了新的临床需求.结合文献以及个人临床实践经验,阐述了PEG-IFNα对慢性乙型肝炎个体化治疗的一些新认识.%Antiviral therapy is the basic treatment of chronic hepatitis B,and pegylated interferon-α is one of the first-line treatment drugs.At present,several consensuses have been reached on individualized treatment with pegylated interferon-o,which is playing an important role in clinical practice.New clinical demands appear along with the clinical application of pegylated interferon-α.With reference to relevant literature and personal clinical experience,this article elaborates on some knowledge of individualized treatment with pegylated interferon-α for chronic hepatitis B.
展开▼
